Brown Advisory Inc. Has $349,000 Position in Teleflex Incorporated (NYSE:TFX)

Brown Advisory Inc. lifted its stake in shares of Teleflex Incorporated (NYSE:TFX) by 34.2% in the first quarter, according to the company in its most recent filing with the SEC. The fund owned 2,524 shares of the medical technology company’s stock after buying an additional 643 shares during the quarter. Brown Advisory Inc.’s holdings in Teleflex were worth $349,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of TFX. MassMutual Private Wealth & Trust FSB boosted its stake in Teleflex by 103.1% during the first quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company’s stock worth $27,000 after acquiring an additional 100 shares in the last quarter. Headlands Technologies LLC bought a new stake in shares of Teleflex in the fourth quarter valued at approximately $29,000. Whipplewood Advisors LLC grew its stake in Teleflex by 7,700.0% during the first quarter. Whipplewood Advisors LLC now owns 234 shares of the medical technology company’s stock valued at $32,000 after acquiring an additional 231 shares in the last quarter. True Wealth Design LLC grew its stake in Teleflex by 62.3% during the fourth quarter. True Wealth Design LLC now owns 271 shares of the medical technology company’s stock valued at $48,000 after acquiring an additional 104 shares in the last quarter. Finally, UMB Bank n.a. grew its stake in Teleflex by 3,763.6% in the 1st quarter. UMB Bank n.a. now owns 425 shares of the medical technology company’s stock worth $59,000 after buying an additional 414 shares in the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Trading Down 1.9%

TFX stock opened at $113.50 on Wednesday. The firm has a market cap of $5.02 billion, a PE ratio of 35.80, a price-to-earnings-growth ratio of 1.81 and a beta of 1.08. The firm has a fifty day moving average price of $121.42 and a 200 day moving average price of $142.61. Teleflex Incorporated has a fifty-two week low of $113.32 and a fifty-two week high of $249.91. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.32 and a current ratio of 2.28.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share for the quarter, topping the consensus estimate of $2.88 by $0.03. The business had revenue of $700.67 million during the quarter, compared to the consensus estimate of $699.37 million. Teleflex had a return on equity of 14.73% and a net margin of 4.96%. The business’s revenue for the quarter was down 5.0% compared to the same quarter last year. During the same period last year, the company earned $3.21 earnings per share. Sell-side analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, June 16th. Stockholders of record on Tuesday, May 20th were paid a dividend of $0.34 per share. The ex-dividend date of this dividend was Tuesday, May 20th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.20%. Teleflex’s payout ratio is 42.90%.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on TFX. Wall Street Zen lowered shares of Teleflex from a “buy” rating to a “hold” rating in a report on Sunday, June 29th. Royal Bank Of Canada cut their price objective on shares of Teleflex from $145.00 to $130.00 and set a “sector perform” rating on the stock in a research report on Tuesday. Truist Financial lowered their target price on shares of Teleflex from $140.00 to $137.00 and set a “hold” rating on the stock in a research note on Monday, May 5th. Morgan Stanley lowered their price objective on shares of Teleflex from $191.00 to $173.00 and set an “overweight” rating on the stock in a research note on Monday, May 5th. Finally, Mizuho set a $155.00 target price on shares of Teleflex in a research note on Wednesday, April 16th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $162.75.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.